Sara Dolcetti is the Director and Head of Business Development and Marketing at Philips Precision Medicine. Previously, she worked in M&A and Investments for Philips and also has experience as a BCG consultant.
She is an expert in project management, change management, strategic planning and business process improvement. She has an extensive background in business strategy and management, and holds an M.B.A. from MIT Sloan School of Management.
Areas of Expertise (6)
Business Process Improvement
Massachusetts Institute of Technology: M.S. 2015
Massachussetts Institute of Technology: M.B.A., Bsuiness Administration 2015
Selected Articles (1)
Analyzing the impact of delays for patient transfers from the ICU to general care unitsMassachusetts Institute of Technology
2015 Patients at Massachusetts General Hospital (MGH) face significant non-clinical transfer delays out of adult intensive care units (ICUs) and into general care units. In each of the years 2010 through to 2013, approximately 28% of MGH ICU patients experienced a transfer delay of over 12 hours. Transfer delays from the ICU impact several aspects of a patient's hospital stay, in that transfer delays: i) Increase the cost of the stay; ii) Increase ICU utilization; iii) May contribute to additional disruptions to patient flow, such as congested access to the ICU from various locations in the hospital; iv) May have clinical implications given that delayed ICU access for critically ill emergency department and operating room patients may affect the clinical care for these patients.